NCT03141359View on ClinicalTrials.gov

Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

July 12, 2023

Study Completion Date

July 31, 2027

Conditions
Lung Cancer Stage IILung Cancer Stage IIINon Small Cell Lung Cancer
Interventions
RADIATION

SBRT

Primary tumor SBRT

DRUG

Carboplatin

concurrent chemotherapy

DRUG

Paclitaxel

concurrent chemotherapy

DRUG

cis Platinum

concurrent chemotherapy

DRUG

Etoposide

concurrent chemotherapy

RADIATION

IMRT

mediastinal radiation

DRUG

Durvalumab

adjuvant immunotherapy

Trial Locations (1)

28204

Levine Cancer Institute, Charlotte

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Atrium Health Levine Cancer Institute

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER